Stem Cell Based Clinical Trial for HLHS

The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome at Mayo Clinic takes another step toward its goal of delaying or preventing heart transplant for people affected with Hypoplastic Left Heart Syndrome, with the announcement of a stem cell-based clinical trial for HLHS. The clinical trial aims to determine how stem cells derived from autologous umbilical cord blood, and then delivered into the muscle of the right side of the heart at the time of the Glenn procedure, can help children with HLHS. Dr Harold Burkhart, pediatric cardiac surgeon at Mayo Clinic, discusses the trial in the video below. https://www.youtube.com/watch?v=jDU7CXijMJg
------------------------------------------------------------------------------------------------------------------------------------

The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science to diagnostic imaging to regenerative therapies.